Jianfeng Cui
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Papers in
- Surgery 15
- Bladder and Urothelial Cancer Treatments 7
- Urinary and Genital Oncology Studies 3
- Co-authors
- Benkang Shi (27 shared papers)Yangyang Xia (13 shared papers)Yaofeng Zhu (15 shared papers)Yongxin Zou (7 shared papers)Pengxiang Chen (9 shared papers)Shuna Sun (5 shared papers)Lipeng Chen (5 shared papers)Shouzhen Chen (10 shared papers)
In The Last Decade
Jianfeng Cui
46 papers receiving 730 citations
Peers
Comparison fields: 5 of 109
- Cancer Research 166
- Oncology 173
- Urology 39
- Molecular Biology 331
- Pulmonary and Respiratory Medicine 149
Countries citing papers authored by Jianfeng Cui
This map shows the geographic impact of Jianfeng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfeng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfeng Cui more than expected).
Fields of papers citing papers by Jianfeng Cui
This network shows the impact of papers produced by Jianfeng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfeng Cui. The network helps show where Jianfeng Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianfeng Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 67 | |
| 2 | 2021 | 62 | |
| 3 | 2015 | 52 | |
| 4 | 2021 | 43 | |
| 5 | 2019 | 39 | |
| 6 | 2021 | 35 | |
| 7 | 2020 | 30 | |
| 8 | 2020 | 29 | |
| 9 | 2020 | 27 | |
| 10 | 2007 | 25 | |
| 11 | 2018 | 21 | |
| 12 | 2017 | 19 | |
| 13 | 2016 | 18 | |
| 14 | 2017 | 18 | |
| 15 | 2020 | 17 | |
| 16 | 2008 | 17 | |
| 17 | 2021 | 15 | |
| 18 | 2017 | 13 | |
| 19 | 2017 | 13 | |
| 20 | 2022 | 12 |
About Jianfeng Cui
Jianfeng Cui is a scholar working on Molecular Biology, Surgery, Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 46 papers that have together received 736 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Cancer, Lipids, and Metabolism (5 papers), Renal cell carcinoma treatment (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Urinary Bladder and Prostate Research (3 papers), Urinary and Genital Oncology Studies (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (166 citations), Oncology (173 citations), Urology (39 citations), Molecular Biology (331 citations) and Pulmonary and Respiratory Medicine (149 citations). Jianfeng Cui has collaborated with scholars based in China, Russia and Canada. Frequent co-authors include Benkang Shi, Yangyang Xia, Yaofeng Zhu, Yongxin Zou, Pengxiang Chen, Shuna Sun, Lipeng Chen, Shouzhen Chen, Wenfu Wang and Xuewen Jiang. Their work appears in journals such as Oncotarget, American Journal of Physiology-Renal Physiology, Oncogene, Scientific Reports and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.